Recursion Pharmaceuticals Inc Clas (RXRX)
Operating Expenses
$131.15M
Quarterly · Period ending: · USD
RXRX Operating Expenses
Latest reported$131.15Mperiod ending
Latest reported$131.15Mperiod ending
RXRX Quarterly Operating Expenses ($18.34M → $131.15M)
Quarterly operating expenses
High-resolution chart · PNG
RXRX operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 131,147,000 | |
| 122,487,000 | |
| 116,996,000 | |
| 147,784,000 | |
| 175,169,000 | |
| 184,284,000 | |
| 175,485,000 | |
| 112,357,000 | |
| 105,748,000 | |
| 98,665,000 | |
| 99,673,000 | |
| 98,775,000 | |
| 83,349,000 | |
| 69,551,000 | |
| 63,818,000 | |
| 60,217,000 | |
| 59,617,000 | |
| 53,481,000 | |
| 67,460,000 | |
| 48,902,000 | |
| 43,429,000 | |
| 32,984,000 | |
| 28,132,000 | |
| 23,336,000 | |
| 18,217,000 | |
| 18,343,000 |